Uncategorized September 25, 2010 0 A Busy Week for Multiple Sclerosis News It was good news for Novartis and bad news for Merck KGaA this week as regulators handed down their decisions on each company’s multiple sclerosis (MS) drug candidate.
Uncategorized September 17, 2010 0 No Shortage of Hopefuls in the Multibillion-Dollar Blood Thinner Business Patients hoping for a new alternative to the blockbuster blood thinner Plavix will have to wait a bit longer for a verdict on a promising candidate.
Uncategorized October 12, 2009 0 Onyx Pharmaceuticals to Acquire Proteolix Onyx Pharmaceuticals has agreed to purchase private biotechnology company Proteolix for $276 million in cash.